Adcock Ingram is set to delist from the JSE as Natco Pharma partners with Bidvest in a major take-private deal.
Adcock Ingram to Delist Amidst Corporate Changes
Original Article by Lindiwe Tsobo | Business Day | 24 July 2025
Adcock Ingram is set to delist from the JSE as Natco Pharma partners with Bidvest in a major take-private deal.
More Posts
Thembisile Xulu Named New Health Director-General
Dr Thembisile Xulu is the new health Director-General, inheriting a strained department, healthcare-worker shortages and NHI litigation.
Read more...
Gauteng Nurse Shortage Deepens, Threatening NHI Rollout
Gauteng is losing 100 nurses a month and needs R5.7bn to fill a 16,000-post gap. This shortage now flagged as a key risk to the NHI rollout.
Read more...
Medical Schemes Should Be Allowed to Offer Low-Cost Benefit Options
Regulation, not demand, blocks affordable cover: medical schemes should be allowed to offer low-cost benefit options (LCBOs) now.
Read more...